All News
FDA OKs Nitisinone for Ultra-Rare Black Urine Disease
(MedPage Today) -- The FDA approved nitisinone (Harliku) for the reduction of urine homogentisic acid (HGA) in adults with alkaptonuria, Cycle Pharmaceuticals announced on Thursday.
Read MoreWith Enhanced Subsidies Set To Expire, Consumers Could Face Higher Obamacare Costs
Get our weekly newsletter, The Week in Brief, featuring a roundup of our original coverage, Fridays at 2 p.m. ET.
Read MoreKFF Health News' 'What the Health?': Supreme Court Upholds Bans on Gender-Affirming Care
The Supreme Court this week said Tennessee may continue to enforce its law banning most types of gender-affirming care for minors. The ruling is likely to greenlight similar laws in two dozen states.
Read MoreGLP-1 Drugs Can Be Used First for Weight Loss, Says American College of Cardiology
(MedPage Today) -- The American College of Cardiology (ACC) gave popular obesity medications equal standing with diet and exercise as a first-line strategy for weight management.
Read MoreSTAT+: Senate Republicans debate Medicaid options as hospitals move to shape legislation
The Senate returns next week with critical choices on Medicaid policies that could cost hospitals billions of dollars and lead to millions losing coverage.
Read MoreSTAT+: Disagreements over Duchenne therapy, management style may have led to ouster of key FDA official
The ouster of the FDA's chief regulator of cell and gene therapies came immediately after a disagreement with her boss over a drug review, STAT has learned.
Read MoreRethinking Maintenance Strategies in Metastatic HER2-Positive Breast Cancer
(MedPage Today) -- With the DESTINY-Breast09 trial, which was presented at this year's American Society of Clinical Oncology (ASCO) annual meeting, suggesting a shift in first-line treatment for HER2
Read MoreSTAT+: FDA’s gene therapy turmoil unpacked
And other biotech news brought to you by The Readout.
Read MoreOne in three across UK are overdue for cervical cancer screening
Screening rates are declining, with some parts of England at greater risk due to low uptake of HPV vaccineA third of people across the UK are overdue their cervical cancer screening, while in parts of
Read MoreBCMA CAR-T Yields 100% Response Rate in Small AL Amyloidosis Trial
(MedPage Today) -- As CAR T-cell therapy has become a transformative option in multiple myeloma, a first-of-its-kind trial now extends that potential to relapsed/refractory light chain (AL) amyloidos
Read More